45 results
10-K
2023 FY
MREO
Mereo Biopharma Group Plc
27 Mar 24
Annual report
5:20pm
that evidence our ADSs;
“AECOPD” are to acute exacerbation of chronic obstructive pulmonary disease;
“BLA” are to Biologics License Application;
“CMA … ” are to Conditional Marketing Authorization;
“CMO” are to contract manufacturing organization;
“COPD” are to chronic obstructive pulmonary disease
6-K
EX-99.2
MREO
Mereo Biopharma Group Plc
7 Sep 23
Current report (foreign)
7:37am
income and expense.”
We plan to partner or sell our other two product candidates, acumapimod for the treatment of acute exacerbation of chronic
6-K
EX-99.2
MREO
Mereo Biopharma Group Plc
2 Nov 22
Current report (foreign)
4:17pm
product candidates, acumapimod for the treatment of acute exacerbation of chronic obstructive pulmonary disease (“AECOPD”) and leflutrozole
6-K
EX-99.1
MREO
Mereo Biopharma Group Plc
17 Oct 22
Mereo BioPharma Receives FDA Fast Track Designation for Alvelestat for Treatment of
7:16am
of breath, wheezing, chronic cough and sputum production, as well as asthma, recurring chest infections and bronchiectasis – permanent enlargement
6-K
MREO
Mereo Biopharma Group Plc
9 May 22
Current report (foreign)
8:06am
progress to chronic oxygen therapy, lung surgery, transplant, and death.
About Alvelestat
Alvelestat (MPH-966) is a novel, oral small molecule designed
6-K
EX-99.1
xtnfq
9 May 22
Current report (foreign)
8:06am
6-K
EX-99.1
hriprv 0v
14 Mar 22
Current report (foreign)
10:05am
6-K
EX-99.2
gdineq1r
2 Nov 21
Current report (foreign)
4:16pm
6-K
EX-99.1
ix5j7rb ql18wyt9zy3
26 Oct 21
Mereo BioPharma Receives U.S. Orphan Drug Designation for alvelestat in About Mereo BioPharma
10:07am
6-K
EX-99.1
ikml2f8 edm2w63w2
2 Jun 21
Current report (foreign)
8:24am
6-K
EX-99.1
kr30e4q pap39qa
29 Sep 20
Current report (foreign)
7:08am
6-K
EX-99.2
cut8nv6tnskn tz03
29 Sep 20
Current report (foreign)
7:08am
6-K
EX-99.1
sq6yl
9 Jun 20
Publication of Circular and Notice of General Meeting
4:15pm
6-K
EX-99.1
eext6qq
27 May 20
Notice of Annual General Meeting
7:37am
6-K
EX-99.1
terra 1nt30o4
22 May 20
Annual General Meeting
9:31am
6-K
EX-99.1
gqx6np2h d613hzdr
27 Mar 20
Business Update and Directorate Change
9:09am